{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:58:21Z","timestamp":1789988301421,"version":"4.0.1"},"reference-count":25,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/mco.2017.1194","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T05:12:38Z","timestamp":1489468358000},"page":"639-642","source":"Crossref","is-referenced-by-count":14,"title":["Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target"],"prefix":"10.3892","volume":"6","author":[{"given":"Heike","family":"Loeser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Waldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kuetting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Heydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Plum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Alakus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Quaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"key20180107152212_b1-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2016.03.015","article-title":"The role of DOT1L in the maintenance of leukemia gene expression","volume":"36","author":"Wang","year":"2016","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107152212_b2-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"30421","DOI":"10.1074\/jbc.C200366200","article-title":"Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase","volume":"277","author":"Lacoste","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107152212_b3-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mrrev.2016.03.005","article-title":"The many faces of histone H3K79 methylation","volume":"768","author":"Farooq","year":"2016","journal-title":"Mutat Res Rev Mutat Res"},{"key":"key20180107152212_b4-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"30451","DOI":"10.18632\/oncotarget.5860","article-title":"DOT1L: A new therapeutic target for aggressive breast cancer","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"key20180107152212_b5-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2014.03.010","article-title":"IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L","volume":"40","author":"Kryczek","year":"2014","journal-title":"Immunity"},{"key":"key20180107152212_b6-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1182\/blood-2011-02-334359","article-title":"DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis","volume":"117","author":"Nguyen","year":"2011","journal-title":"Blood"},{"key":"key20180107152212_b7-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biochi.2016.01.005","article-title":"DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines","volume":"123","author":"Oktyabri","year":"2016","journal-title":"Biochimie"},{"key":"key20180107152212_b8-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.3748\/wjg.v22.i31.6987","article-title":"FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer","volume":"22","author":"Caparello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20180107152212_b9-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pan.2015.10.013","article-title":"IAP\/EPC study group on the clinical managements of pancreatic cancer: International Association of Pancreatology (IAP)\/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer","volume":"16","author":"Takaori","year":"2016","journal-title":"Pancreatology"},{"key":"key20180107152212_b10-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/postgradmedj-2014-133222","article-title":"Pancreatic cancer: Current management and treatment strategies","volume":"91","author":"Gall","year":"2015","journal-title":"Postgrad Med J"},{"key":"key20180107152212_b11-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/bjs.4484","article-title":"Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma","volume":"91","author":"Wagner","year":"2004","journal-title":"Br J Surg"},{"key":"key20180107152212_b12-mco-0-0-1194","first-page":"70","article-title":"The role of surgery for pancreatic cancer: A 12-year review of patient outcome","volume":"79","author":"Badger","year":"2010","journal-title":"Ulster Med J"},{"key":"key20180107152212_b13-mco-0-0-1194","first-page":"257","article-title":"Tissue microarrays","volume":"114","author":"Simon","year":"2005","journal-title":"Methods Mol Med"},{"key":"key20180107152212_b14-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"21763","DOI":"10.18632\/oncotarget.7845","article-title":"Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"7","author":"Helbig","year":"2016","journal-title":"Oncotarget"},{"key":"key20180107152212_b15-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"e98270","DOI":"10.1371\/journal.pone.0098270","article-title":"DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"key20180107152212_b16-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MOH.0000000000000123","article-title":"Mixed lineage rearranged leukaemia: Pathogenesis and targeting DOT1L","volume":"22","author":"Stein","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"key20180107152212_b17-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2012-11-465120","article-title":"Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l","volume":"121","author":"Deshpande","year":"2013","journal-title":"Blood"},{"key":"key20180107152212_b18-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","article-title":"hDOT1L links histone methylation to leukemogenesis","volume":"121","author":"Okada","year":"2005","journal-title":"Cell"},{"key":"key20180107152212_b19-mco-0-0-1194","first-page":"2823","article-title":"The histone methyltransferase DOT1L: Regulatory functions and a cancer therapy target","volume":"5","author":"Wong","year":"2015","journal-title":"Am J Cancer Res"},{"key":"key20180107152212_b20-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"10665","DOI":"10.18632\/oncotarget.2496","article-title":"Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget"},{"key":"key20180107152212_b21-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1038\/ncomms8821","article-title":"DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression","volume":"6","author":"Cho","year":"2015","journal-title":"Nat Commun"},{"key":"key20180107152212_b22-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4161\/cc.28104","article-title":"The histone methyltransferase Dot1\/DOT1L as a critical regulator of the cell cycle","volume":"13","author":"Kim","year":"2014","journal-title":"Cell Cycle"},{"key":"key20180107152212_b23-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"key20180107152212_b24-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.114.214577","article-title":"DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells","volume":"350","author":"Klaus","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107152212_b25-mco-0-0-1194","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc2899","article-title":"KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma","volume":"10","author":"Morris","year":"2010","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2017.1194\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T10:22:22Z","timestamp":1515320542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,14]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/mco.2017.1194"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1194","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}